Asset Allocation & Management Company, LLC Eli Lilly & CO Transaction History

Asset Allocation & Management Company, LLC

$159 Million
Q3 2024

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	BUY	$224.85 - $279.04 $831,045 - $1.03 Million	3,696 New	3,696 $1.02 Million
Q2 2020 Nov 16, 2020	SELL	$136.42 - $164.18 $286,482 - $344,778	-2,100 Closed	0 $0
Q1 2020 Nov 16, 2020	BUY	$119.05 - $147.35 $68,096 - $84,284	572 Added 37.43%	2,100 $291,000
Q4 2019 Nov 13, 2020	BUY	$106.92 - $132.43 $163,373 - $202,353	1,528 New	1,528 $201,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

Lilly Endowment Inc Indianapolis, IN

96.9M
Shares

$77.1 Billion
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

73.8M
Shares

$58.7 Billion
1.2% of portfolio
Black Rock Inc. New York, NY

65.9M
Shares

$52.4 Billion
1.37% of portfolio
Pnc Financial Services Group, Inc. Pittsburgh, PA

51.4M
Shares

$40.9 Billion
29.2% of portfolio
State Street Corp Boston, MA

33.9M
Shares

$26.9 Billion
1.24% of portfolio

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Asset Allocation & Management Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Asset Allocation & Management Company, LLC with notifications on news.

Account